Product Description

Elongation factor 2 Monoclonal Antibody

Sizes: 50µl, 100µl

Catalogue Numbers: MB12008-50, MB12008-100

Product: 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA

Swiss-Prot: P13639

Host: Rabbit

Reactivity: Human, Mouse, Rat

Applications: WB, IHC-F, IHC-P, ICC/IF, IP,

All Applications: WB: 1/500-1/1000 IHC: 1/50-1/100 IF: 1/50-1/200 IP: 1/20

Background: Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively.

Purification and Purity: Affinity Purified

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: IgG

Bioworld Molecular Weight: Calculated MW: 95 kDa; Observed MW: 95 kDa

Note: For research use only, not for use in diagnostic procedure.

Extra Notes: Immunocytochemistry analysis of Elongation factor 2 in Hela using Elongation factor 2 antibody, and DAPI., Western blot analysis of EEF2/Elongation factor 2 in 3T3, MEF lysates using EEF2/Elongation factor 2 antibody., Western blot analysis of EEF2/Elongation factor 2 in A549, U2OS, C6 lysates using EEF2/Elongation factor 2 antibody, Immunohistochemistry analysis of paraffin-embedded Human breast cancer using EEF2/Elongation factor 2 antibody. High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.

Alternative Name: EEF2; EF2; Elongation factor 2; EF-2

Immunogen: A synthetic peptide of human EEF2/Elongation factor 2

Conjugate: Unconjugated

Modification: Unmodified